Teva Pharmaceutical Industries Ltd.
Asset & Liabilities Breakdown
Asset Breakdown FY2025
Total Assets: $40.75B
Liabilities Breakdown FY2025
Total Liabilities: $32.83B
Asset Breakdown
Total Assets: $40.75B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $3.56B | 8.7% |
| Accounts Receivable | $3.71B | 9.1% |
| Inventory | $3.18B | 7.8% |
| Property, Plant & Equipment | $4.08B | 10.0% |
| Goodwill | $16.00B | 39.3% |
| Intangible Assets | $3.78B | 9.3% |
| Other Assets | $6.44B | 15.8% |
Liabilities Breakdown
Total Liabilities: $32.83B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $225.0M | 0.7% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $32.61B | 99.3% |